Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation / Napolitano, ; Martini, ; Martinelli, ; Belli, ; Parascandolo, ; Laukkanen, M; Sforza, ; Morgillo, ; Ciardiello, ; Ciardiello, ; Troiani,. - In: ONCOTARGET. - ISSN 1949-2553. - (2017).
Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation
Laukkanen M;
2017
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Napolitano 2017.pdf
non disponibili
Dimensione
2.27 MB
Formato
Adobe PDF
|
2.27 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
